Abstract 5927: Assessing the efficacy of a novel gene therapy approach for treating ovarian cancer: Combination RRV-mediated prodrug activated suicide gene therapy

Journal article

Peer reviewed

James Grosso, Sara Collins, Aki Inagaki, Brian Slomovitz and Noriyuki Kasahara

Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.5927-5927

2018-07-01

Metrics

3 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Abstract 5927: Assessing the efficacy of a novel gene therapy approach for treating ovarian cancer: Combination RRV-mediated prodrug activated suicide gene therapy
Creators: James Grosso
Sara Collins
Aki Inagaki
Brian Slomovitz
Noriyuki Kasahara
Publication Details: Cancer research (Chicago, Ill.), Vol.78(13 Supplement), pp.5927-5927
Academic Unit: Miller School of Medicine; UMMG Dept of Obstetrics & Gynecology
Language: English
Resource Type: Journal article
Record Identifier: 991031597969702976